Synthesis and biological activity of Magnesium(II) complexes of heptaaza Schiff base macrocyclic ligands; 1H and 13C chemical shifts computed by the GIAO-DFT and CSGT-DFT methodologies

Two new pendant armed Schiff base macrocyclic complexes, [MgL1](ClO4)2 (1), and [MgL2](ClO4)2 (2), have been prepared via cyclocondensation of 2,6-diformylpyridine and 2,6-diacetylpyridine with two hexadentate hexaamines, ten and tmen, in the presence of Mg(II) ion. The ligands are 15-membered pentaaza macrocycles having two 2-aminoethyl pendant arms. The newly prepared complexes are investigated by IR, 1H NMR, 13C{1H} NMR, DEPT(135), COSY(H, H) and HMQC spectroscopic methods. The antimicrobial screening of newly prepared complexes, 1 and 2, as well as previously prepared similar complexes, [MgL3](ClO4)2 (3) and [MgL4](ClO4)2 (4), against Escherichia coli, Staphylococcus aureus and candidia albicans showed that the macrocyclic complexes of Mg(II) containing 15-membered pentaaza ring (1, 2 and 3) have no activity. Where as the compound 4, which contain 16-membered pentaaza ring, had remarkable inhibition zone on the culture of S. aureus and E. coli as compared with standard drugs. The 1H and 13C chemical shieldings of gas phase complexes were also studied by the gauge independent atomic orbital (GIAO) and continuous set of gauge transformations (CSGT) methods at the level of density functional theory (DFT). The computed 13C chemical shifts are in reasonably good agreement with the experimental data.